Combination of von Willebrand disease type 1 and partial factor XII deficiency in children: Clinical evidence for a diminished bleeding tendency

Acta Paediatrica, International Journal of Paediatrics

Volumn 88, Issue 11, 1999, Pages 1233-1237

  Zeitler, P ^a   Meissner, N ^a   Kreth, H W ^a  

^a UNIVERSITY OF WÜRZBURG   (Germany)

Author keywords

Bleeding tendency; Factor XII; von Willebrand disease

Indexed keywords

BLOOD CLOTTING FACTOR 12; RISTOCETIN;

ARTICLE; BLEEDING TENDENCY; BLOOD CLOTTING FACTOR 12 DEFICIENCY; DISEASE COURSE; GENETIC ASSOCIATION; HUMAN; HUMAN CELL; HUMAN TISSUE; MAJOR CLINICAL STUDY; PATHOPHYSIOLOGY; PRIORITY JOURNAL; TREATMENT OUTCOME; VON WILLEBRAND DISEASE;

EID: 0032748448     PISSN: 08035253     EISSN: None     Source Type: Journal    
DOI: 10.1080/080352599750030347     Document Type: Article

References (16)

1. Corrigan J. Hemostasis: general considerations. In: Miller DR, Baehner RL, editors. Blood diseases of infancy and childhood. St. Louis: CV Mosby, 1990: 761-76
2. Ruggeri ZM, Ware J. The structure and function of von Willebrand factor. Thromb Haemost 1992; 67: 594-9
3. Koppelman SJ, van Hoeij M, Vink T, Lankhof H, Schiphorst ME, Damas C, et al. Requirements of von Willebrand factor to protect factor VIII from inactivation by activated protein C. Blood 1996; 87: 2292-300
4. Sadler JE. A revised classification of von Willebrand disease. Thromb Haemost 1994; 71: 520-5
5. Schneppenheim R, Thomas KB, Sutor AH. Von Willebrand disease in childhood. Semin Thromb Hemost 1995; 21: 261-75
6. Halbmayer WM, Mannhalter C, Feichtinger C, Rubi K, Fischer M. The prevalence of factor XII deficiency in 103 orally anticoagulated outpatients suffering from recurrent venous and/ or arterial thromboembolism. Thromb Haemost 1992; 68: 285-90
7. Ratnoff OD. A quarter century with Mr. Hageman. Thromb Haemost 1980; 43: 95-8
8. Négrier C, Delmas MC, Ranchin B, Cochat P, Dechavanne M. Decreased factor XII activity in a child with nephrotic syndrome and thromboembolic complications. Thromb Haemost 1991; 66: 512-3
9. Bick RL, Baker WF. Antiphospholipid and thrombosis syndrome. Semin Thromb Hemost 1994; 20: 3-15
10. Bernardi F, Marchetti G, Volinia S, Patracchini P, Casonato A, Girolami A, et al. A frequent factor XII gene mutation in Hageman trait. Hum Genet 1988; 80: 149-51
11. Korte W, Otremba H, Lutz S, Flury R, Schmidt L, Weissert M. Childhood stroke at three years of age with transient protein C deficiency, familial antiphospholipid antibodies and F XII deficiency - a family study. Neuropediatrics 1994; 25: 290-4
12. Cramer AD, Melaragno AJ, Phifer SJ, Hougie C. Von Willebrand disease San Diego, a new variant. Lancet 1976; 2: 12-4
13. Barthels M, Edel J, Liese B, Karge HE. Additional factor XII (Hageman factor) deficiency in hemophilia A and in von Willebrand syndrome. Klin Wochenschr 1982; 60: 303-9
14. Triplett D. Laboratory diagnosis of von Willebrand's disease. Mayo Clin Proc 1991; 66: 832-40
15. Andrew M, Paes B, Milner R, Johnston M, Mitchell L, Tollefsen DM, et al. Development of the human coagulation system in the healthy premature infant. Blood 1988; 72: 1651-7
16. Wachtfogel Y, DeLa Cadena R, Culman R. Structural biology, cellular interactions and pathophysiology of the contact system. Thromb Res 1993, 72: 1-21